Evolving neurobiology of tuberous sclerosis complex

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Tuberous Sclerosis Complex (TSC) is a genetic disorder affecting multiple organs.
• Advances in identifying TSC1 and TSC2 genes have linked TSC to the mammalian target of rapamycin (mTOR) signaling pathway.

Purpose of the Study:

• To review recent advances in understanding TSC molecular pathogenesis.
• To discuss the development of therapeutic interventions for TSC.
• To highlight future research directions for TSC.

Main Methods:

• Review of molecular pathogenesis studies.
• Analysis of genetic findings (TSC1, TSC2).
• Examination of mTOR pathway involvement.
• In vitro systems, rodent models, and human tissue analysis.

Main Results:

• Identification of TSC1 and TSC2 genes and their link to mTOR signaling.
• Development of new therapeutic strategies, including approved treatments for TSC.
• Establishment of cell lines and mouse models for studying TSC-related brain abnormalities.
• Insights into the formation of brain lesions in TSC.

Conclusions:

• TSC research exemplifies a successful bench-to-bedside translational model.
• Understanding TSC clinical variability and genotype-phenotype correlations remains a challenge.
• Biomarker identification is crucial for TSC prognosis and patient stratification.